Prelude Therapeutics (PRLD) Shares Outstanding (2024 - 2025)
Historic Shares Outstanding for Prelude Therapeutics (PRLD) over the last 2 years, with Q3 2025 value amounting to $43.8 million.
- Prelude Therapeutics' Shares Outstanding rose 372.72% to $43.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.8 million, marking a year-over-year increase of 372.72%. This contributed to the annual value of $42.3 million for FY2024, which is N/A changed from last year.
- Per Prelude Therapeutics' latest filing, its Shares Outstanding stood at $43.8 million for Q3 2025, which was up 372.72% from $43.7 million recorded in Q2 2025.
- Prelude Therapeutics' Shares Outstanding's 5-year high stood at $43.8 million during Q3 2025, with a 5-year trough of $42.1 million in Q1 2024.